Literature DB >> 8098490

Taxol and radiation recall dermatitis.

V T Raghavan, W D Bloomer, D E Merkel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098490     DOI: 10.1016/0140-6736(93)90871-d

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Radiation recall in a patient with breast cancer treated for tuberculosis.

Authors:  M Extermann; N Vogt; M Forni; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer.

Authors:  Xiao Ding; Wei Ji; Junling Li; Xiangru Zhang; Luhua Wang
Journal:  Radiat Oncol       Date:  2011-03-06       Impact factor: 3.481

Review 3.  Prevention and management of extravasation of cytotoxic drugs.

Authors:  G Bertelli
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

4.  Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report.

Authors:  Christian Spirig; Aurelius Omlin; Giannicola D'Addario; Klaus-Dieter Loske; Philipp Esenwein; Jan Henning Geismar; Thomas Ruhstaller
Journal:  J Med Case Rep       Date:  2009-11-02

Review 5.  A review of clinical experience with paclitaxel extravasations.

Authors:  Brad L Stanford; Fred Hardwicke
Journal:  Support Care Cancer       Date:  2003-03-27       Impact factor: 3.603

6.  Locoregional interaction of ixabepilone (ixempra) after breast cancer radiation.

Authors:  Vinita Takiar; Eric A Strom; Donald P Baumann; Funda Meric-Bernstam; Ricardo H Alvarez; Ana M Gonzalez-Angulo
Journal:  Oncologist       Date:  2013-02-12

Review 7.  Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer.

Authors:  C M Spencer; D Faulds
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

8.  Radiation recall dermatitis: case report and review of the literature.

Authors:  A E Hird; J Wilson; S Symons; E Sinclair; M Davis; E Chow
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.